Ligand validation:5IFT

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 5IFT designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5IFT_NAG_A_1760	63%	61%	0.161	0.958	0.36	1.12	-	2	1	0	100%	1
5IFT_NAG_A_1739	62%	70%	0.139	0.932	0.3	0.84	-	1	0	0	100%	1
5IFT_NAG_A_1777	44%	67%	0.188	0.914	0.34	0.9	-	1	0	0	100%	1
5IFT_NAG_A_1478	22%	67%	0.276	0.897	0.41	0.85	-	-	0	0	100%	1
5IFT_NAG_A_1522	19%	74%	0.271	0.866	0.22	0.79	-	-	0	0	100%	1
5IFT_NAG_A_1156	10%	66%	0.378	0.884	0.45	0.84	-	1	0	0	100%	1
5MGD_NAG_A_1760	67%	57%	0.117	0.924	0.34	1.27	-	1	0	0	100%	1
5JUV_NAG_A_1760	62%	48%	0.13	0.922	0.42	1.56	-	2	2	0	100%	1
5IHR_NAG_A_1777	60%	58%	0.143	0.928	0.5	1.11	-	2	0	0	100%	1
5MGC_NAG_A_1760	55%	54%	0.125	0.894	0.49	1.26	-	2	1	0	100%	1
5IFP_NAG_A_1777	54%	77%	0.121	0.884	0.29	0.61	-	-	0	0	100%	1
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	1
5F9W_NAG_A_510	100%	88%	0.023	0.994	0.24	0.43	-	-	0	0	100%	1
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	1
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	1
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.